FDA
-
-
-
-
-
-
-
Schrödinger Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
-
-
-
-
-
-
-
Schrodinger Inc. (SDGR) Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event
-
-
-
-
-
-
-
Schrodinger Inc. (SDGR) Granted FDA Clearance of IND for SGR-1505
-
-
-
-
-
-
-
Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/21: (BXRX) (CRC) (DBX) Higher (TRUE) (BXC) (EYPT) Lower (more...)
328,553 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

